Cuba Plans to Produce 10 Mln Doses of Hemophilia Flu Vaccines Annually
Posted on: Friday, 9 December 2005, 09:00 CST
Cuba plans to produce 10 mln doses of hemophilia flu vaccines annually
HAVANA, Dec. 8 (Xinhua) -- Cuba is planning to produce at least 10 million doses a year of a vaccine containing synthetic antigens against influenza hemophilia B, the vaccine's inventor said on Thursday.
Vicente Verez from the University of Havana's Antigen Research Center made the announcement during the 18th International Chemistry Conference in Santiago de Cuba, 860 km southeast of Cuba's capital Havana.
Verez said the vaccine is the first of its kind in the world to use synthetic antigens as a base. He said he had seen positive results among inoculated children.
He said the vaccine would soon be exported and become available in some other countries.
Verez said vaccines against hemophilia flu were first developed in several industrial countries and few in underdeveloped nations could afford them as the prices are usually very high.
The scientist also said Cuba is working on a new project that promises to cure haemophilia flu and five other diseases in one shot.
Source: Xinhua News Agency - CEIS
Related Articles
- Take Care Health Systems to Offer Flu Vaccinations Nationwide
- Aetna To Offer Flu Shots For Members At More Than 25,000 Locations
- Aetna to Offer Flu Shots for Members at Target Locations Nationwide
- Aetna to Offer Flu Shots for Members at More Than 25,000 Locations Nationwide
- Summary Box: Call for New Bird Flu Shot
- US Aims to Speed Flu Vaccine Development
- Vaccine Shortage Impacts Publix Flu Shot Program
- Time to Get Shots for Flu, Pneumonia
- Aetna Announces Convenient Option for Members to Receive Flu Shots; Company Urges Vaccination for Members in High Risk Groups
 |
 |
User Comments (0)
RSS Feeds